Liquid Biopsy | February Roundup
Liquid biopsy (LBx) saw several steps forward in February, with coverage decisions from Medicare and commercial payors as well as multiple collaborations.
March 7, 2023
Diagnostics will win the war on disease. From screening to surveillance, digital to DNA, and everything in between, diagnostic developments will improve all aspects of wellness and disease management. DeciBio works with all types of diagnostic companies and technologies to make this a reality.
See how we’ve helped ambitious clients achieve extraordinary outcomes.